Florian Fischer

Frequent and Focal <i>FGFR1</i> Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer

Jonathan M. Weiss, Martin L. Sos, Danila Seidel et al. · Science Translational Medicine · 2010 · 825 citations

Medicine, Cancer Biology, Oncology +14

<i>PTEN</i> Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR

Martin L. Sos, Mirjam Koker, Barbara A. Weir et al. · Cancer Research · 2009 · 495 citations · Full text

Medicine, Molecular Biology, Oncology +17

Predicting drug susceptibility of non–small cell lung cancers based on genetic lesions

Martin L. Sos, Kathrin Michel, Thomas Zander et al. · Journal of Clinical Investigation · 2009 · 263 citations · Full text

Medicine, Molecular Biology, Oncology +17

Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer

Martin L. Sos, Stefanie Fischer, Roland T. Ullrich et al. · Proceedings of the National Academy of Sciences · 2009 · 256 citations · Full text

Medicine, Genetics, Oncology +17

Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance Mutation

Martin L. Sos, Haridas B. Rode, Stefanie Heynck et al. · Cancer Research · 2010 · 219 citations · Full text

Medicine, Oncology, Pharmacology +15